4-Methylthioamphetamine (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "4-Methylthioamphetamine" in English language version.

refsWebsite

Global rank English rank

14nih.gov

4^th place

13doi.org

2^nd place

4semanticscholar.org

11^th place

8^th place

3web.archive.org

1^st place

2europa.eu

68^th place

117^th place

1in.gov.br

3,151^st place

5,932^nd place

1harvard.edu

18^th place

17^th place

1dea.gov

8,191^st place

5,785^th place

dea.gov

"Ecstasy Or MDMA (also Known As Molly)". www.dea.gov. Archived from the original on 2022-08-21. Retrieved 2022-08-21.

doi.org

Huang X, Marona-Lewicka D, Nichols DE (December 1992). "p-methylthioamphetamine is a potent new non-neurotoxic serotonin-releasing agent". European Journal of Pharmacology. 229 (1): 31–38. doi:10.1016/0014-2999(92)90282-9. PMID 1473561.
Murphy J, Flynn JJ, Cannon DM, Guiry PJ, McCormack P, Baird AW, et al. (May 2002). "In vitro neuronal and vascular responses to 5-hydroxytryptamine: modulation by 4-methylthioamphetamine, 4-methylthiomethamphetamine and 3,4-methylenedioxymethamphetamine". European Journal of Pharmacology. 444 (1–2): 61–67. doi:10.1016/S0014-2999(02)01586-8. PMID 12191583.
Poortman AJ, Lock E (March 1999). "Analytical profile of 4-methylthioamphetamine (4-MTA), a new street drug". Forensic Science International. 100 (3): 221–233. doi:10.1016/S0379-0738(98)00214-X. PMID 10423848.
Nutt D, King LA, Saulsbury W, Blakemore C (March 2007). "Development of a rational scale to assess the harm of drugs of potential misuse". Lancet. 369 (9566): 1047–1053. doi:10.1016/s0140-6736(07)60464-4. PMID 17382831. S2CID 5903121.
Nichols D (January 2011). "Legal highs: the dark side of medicinal chemistry". Nature. 469 (7328): 7. Bibcode:2011Natur.469....7N. doi:10.1038/469007a. PMID 21209630.
Błachut D, Wojtasiewicz K, Czarnocki Z, Szukalski B (November 2009). "The analytical profile of some 4-methylthioamphetamine (4-MTA) homologues". Forensic Science International. 192 (1–3): 98–114. doi:10.1016/j.forsciint.2009.08.009. PMID 19766415.
Elliott SP (March 2000). "Fatal poisoning with a new phenylethylamine: 4-methylthioamphetamine (4-MTA)". Journal of Analytical Toxicology. 24 (2): 85–89. doi:10.1093/jat/24.2.85. PMID 10732944. ^{[verification needed]}
De Letter EA, Coopman VA, Cordonnier JA, Piette MH (2001). "One fatal and seven non-fatal cases of 4-methylthioamphetamine (4-MTA) intoxication: clinico-pathological findings". International Journal of Legal Medicine. 114 (6): 352–356. doi:10.1007/s004140100204. PMID 11508803. S2CID 45796753. ^{[verification needed]}
Decaestecker T, De Letter E, Clauwaert K, Bouche MP, Lambert W, Van Bocxlaer J, et al. (2001). "Fatal 4-MTA intoxication: development of a liquid chromatographic-tandem mass spectrometric assay for multiple matrices". Journal of Analytical Toxicology. 25 (8): 705–710. doi:10.1093/jat/25.8.705. PMID 11765028. ^{[verification needed]}
Smets G, Bronselaer K, De Munnynck K, De Feyter K, Van de Voorde W, Sabbe M (August 2005). "Amphetamine toxicity in the emergency department". European Journal of Emergency Medicine. 12 (4): 193–197. doi:10.1097/00063110-200508000-00010. PMID 16034267. S2CID 40206693. ^{[verification needed]}
Błachut D, Wojtasiewicz K, Krawczyk K, Maurin J, Szawkało J, Czarnocki Z (March 2012). "Identification and synthesis of by-products found in 4-methylthioamphetamine (4-MTA) produced by the Leuckart method". Forensic Science International. 216 (1–3): 108–120. doi:10.1016/j.forsciint.2011.09.005. PMID 21982394.
Ewald AH, Peters FT, Weise M, Maurer HH (September 2005). "Studies on the metabolism and toxicological detection of the designer drug 4-methylthioamphetamine (4-MTA) in human urine using gas chromatography-mass spectrometry". Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences. 824 (1–2): 123–131. doi:10.1016/j.jchromb.2005.07.007. PMID 16027051.
Carmo H, Hengstler JG, de Boer D, Ringel M, Carvalho F, Fernandes E, et al. (February 2004). "Comparative metabolism of the designer drug 4-methylthioamphetamine by hepatocytes from man, monkey, dog, rabbit, rat and mouse". Naunyn-Schmiedeberg's Archives of Pharmacology. 369 (2): 198–205. doi:10.1007/s00210-003-0850-0. PMID 14676987. S2CID 35836705.

europa.eu

emcdda.europa.eu

"Report on the Risk Assessment of 4-MTA in the Framework of the Joint Action on New Synthetic Drugs" (PDF). Joint Action on New Synthetic Drugs: 8. 1999-05-19. Archived (PDF) from the original on 2020-09-18. Retrieved 2022-08-21 – via European Monitoring Centre for Drugs and Drug Addiction.
"Report on the Rist Assessment of 4-MTA in the Framework of the Joint Action on New Synthetic Drugs" (PDF). 1999-05-19.

harvard.edu

ui.adsabs.harvard.edu

Nichols D (January 2011). "Legal highs: the dark side of medicinal chemistry". Nature. 469 (7328): 7. Bibcode:2011Natur.469....7N. doi:10.1038/469007a. PMID 21209630.

in.gov.br

Anvisa (2023-07-24). "RDC Nº 804 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial" [Collegiate Board Resolution No. 804 - Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control] (in Brazilian Portuguese). Diário Oficial da União (published 2023-07-25). Archived from the original on 2023-08-27. Retrieved 2023-08-27.

nih.gov

pubmed.ncbi.nlm.nih.gov

Huang X, Marona-Lewicka D, Nichols DE (December 1992). "p-methylthioamphetamine is a potent new non-neurotoxic serotonin-releasing agent". European Journal of Pharmacology. 229 (1): 31–38. doi:10.1016/0014-2999(92)90282-9. PMID 1473561.
Li Q, Murakami I, Stall S, Levy AD, Brownfield MS, Nichols DE, Van de Kar LD (December 1996). "Neuroendocrine pharmacology of three serotonin releasers: 1-(1,3-benzodioxol-5-yl)-2-(methylamino)butane (MBDB), 5-methoxy-6-methyl-2-aminoindan (MMAi) and p-methylthioamphetamine (MTA)". The Journal of Pharmacology and Experimental Therapeutics. 279 (3): 1261–1267. PMID 8968349.
Murphy J, Flynn JJ, Cannon DM, Guiry PJ, McCormack P, Baird AW, et al. (May 2002). "In vitro neuronal and vascular responses to 5-hydroxytryptamine: modulation by 4-methylthioamphetamine, 4-methylthiomethamphetamine and 3,4-methylenedioxymethamphetamine". European Journal of Pharmacology. 444 (1–2): 61–67. doi:10.1016/S0014-2999(02)01586-8. PMID 12191583.
Poortman AJ, Lock E (March 1999). "Analytical profile of 4-methylthioamphetamine (4-MTA), a new street drug". Forensic Science International. 100 (3): 221–233. doi:10.1016/S0379-0738(98)00214-X. PMID 10423848.
Nutt D, King LA, Saulsbury W, Blakemore C (March 2007). "Development of a rational scale to assess the harm of drugs of potential misuse". Lancet. 369 (9566): 1047–1053. doi:10.1016/s0140-6736(07)60464-4. PMID 17382831. S2CID 5903121.
Nichols D (January 2011). "Legal highs: the dark side of medicinal chemistry". Nature. 469 (7328): 7. Bibcode:2011Natur.469....7N. doi:10.1038/469007a. PMID 21209630.
Błachut D, Wojtasiewicz K, Czarnocki Z, Szukalski B (November 2009). "The analytical profile of some 4-methylthioamphetamine (4-MTA) homologues". Forensic Science International. 192 (1–3): 98–114. doi:10.1016/j.forsciint.2009.08.009. PMID 19766415.
Elliott SP (March 2000). "Fatal poisoning with a new phenylethylamine: 4-methylthioamphetamine (4-MTA)". Journal of Analytical Toxicology. 24 (2): 85–89. doi:10.1093/jat/24.2.85. PMID 10732944. ^{[verification needed]}
De Letter EA, Coopman VA, Cordonnier JA, Piette MH (2001). "One fatal and seven non-fatal cases of 4-methylthioamphetamine (4-MTA) intoxication: clinico-pathological findings". International Journal of Legal Medicine. 114 (6): 352–356. doi:10.1007/s004140100204. PMID 11508803. S2CID 45796753. ^{[verification needed]}
Decaestecker T, De Letter E, Clauwaert K, Bouche MP, Lambert W, Van Bocxlaer J, et al. (2001). "Fatal 4-MTA intoxication: development of a liquid chromatographic-tandem mass spectrometric assay for multiple matrices". Journal of Analytical Toxicology. 25 (8): 705–710. doi:10.1093/jat/25.8.705. PMID 11765028. ^{[verification needed]}
Smets G, Bronselaer K, De Munnynck K, De Feyter K, Van de Voorde W, Sabbe M (August 2005). "Amphetamine toxicity in the emergency department". European Journal of Emergency Medicine. 12 (4): 193–197. doi:10.1097/00063110-200508000-00010. PMID 16034267. S2CID 40206693. ^{[verification needed]}
Błachut D, Wojtasiewicz K, Krawczyk K, Maurin J, Szawkało J, Czarnocki Z (March 2012). "Identification and synthesis of by-products found in 4-methylthioamphetamine (4-MTA) produced by the Leuckart method". Forensic Science International. 216 (1–3): 108–120. doi:10.1016/j.forsciint.2011.09.005. PMID 21982394.
Ewald AH, Peters FT, Weise M, Maurer HH (September 2005). "Studies on the metabolism and toxicological detection of the designer drug 4-methylthioamphetamine (4-MTA) in human urine using gas chromatography-mass spectrometry". Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences. 824 (1–2): 123–131. doi:10.1016/j.jchromb.2005.07.007. PMID 16027051.
Carmo H, Hengstler JG, de Boer D, Ringel M, Carvalho F, Fernandes E, et al. (February 2004). "Comparative metabolism of the designer drug 4-methylthioamphetamine by hepatocytes from man, monkey, dog, rabbit, rat and mouse". Naunyn-Schmiedeberg's Archives of Pharmacology. 369 (2): 198–205. doi:10.1007/s00210-003-0850-0. PMID 14676987. S2CID 35836705.

semanticscholar.org

api.semanticscholar.org

Nutt D, King LA, Saulsbury W, Blakemore C (March 2007). "Development of a rational scale to assess the harm of drugs of potential misuse". Lancet. 369 (9566): 1047–1053. doi:10.1016/s0140-6736(07)60464-4. PMID 17382831. S2CID 5903121.
De Letter EA, Coopman VA, Cordonnier JA, Piette MH (2001). "One fatal and seven non-fatal cases of 4-methylthioamphetamine (4-MTA) intoxication: clinico-pathological findings". International Journal of Legal Medicine. 114 (6): 352–356. doi:10.1007/s004140100204. PMID 11508803. S2CID 45796753. ^{[verification needed]}
Smets G, Bronselaer K, De Munnynck K, De Feyter K, Van de Voorde W, Sabbe M (August 2005). "Amphetamine toxicity in the emergency department". European Journal of Emergency Medicine. 12 (4): 193–197. doi:10.1097/00063110-200508000-00010. PMID 16034267. S2CID 40206693. ^{[verification needed]}
Carmo H, Hengstler JG, de Boer D, Ringel M, Carvalho F, Fernandes E, et al. (February 2004). "Comparative metabolism of the designer drug 4-methylthioamphetamine by hepatocytes from man, monkey, dog, rabbit, rat and mouse". Naunyn-Schmiedeberg's Archives of Pharmacology. 369 (2): 198–205. doi:10.1007/s00210-003-0850-0. PMID 14676987. S2CID 35836705.

web.archive.org

Anvisa (2023-07-24). "RDC Nº 804 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial" [Collegiate Board Resolution No. 804 - Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control] (in Brazilian Portuguese). Diário Oficial da União (published 2023-07-25). Archived from the original on 2023-08-27. Retrieved 2023-08-27.
"Report on the Risk Assessment of 4-MTA in the Framework of the Joint Action on New Synthetic Drugs" (PDF). Joint Action on New Synthetic Drugs: 8. 1999-05-19. Archived (PDF) from the original on 2020-09-18. Retrieved 2022-08-21 – via European Monitoring Centre for Drugs and Drug Addiction.
"Ecstasy Or MDMA (also Known As Molly)". www.dea.gov. Archived from the original on 2022-08-21. Retrieved 2022-08-21.